Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Nidorf

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Circulation|January 13, 1999
Assessment of LV mass by echocardiographyM Nidorf, B McQuillan
Journal of the American Heart Association|August 26, 2015
Is There a Role for Colchicine in Acute Coronary Syndromes?Stefan M Nidorf, Subodh Verma
The Medical Journal of Australia|April 17, 1989
Coronary thrombolysisP L Thompson, M Nidorf
The Medical Journal of Australia|October 3, 1988
Coronary thrombolysis: an important therapy for myocardial infarctionM Nidorf, P L Thompson
American Family Physician|December 1, 1995
Proctalgia fugaxD M Nidorf, E R Jamison
The Medical Journal of Australia|January 4, 1988
Valvular surgery in Western Australia: a 15-year reviewM Nidorf, O Tofler, P Gibson, et al.
The Journal of Family Practice|June 1, 1994
Comparison of two topical preparations for the treatment of onychomycosis: Melaleuca alternifolia (tea tree) oil and clotrimazoleD S Buck, D M Nidorf, J G Addino
Journal of Cardiovascular Pharmacology and Therapeutics|September 17, 2013
Targeting cholesterol crystal-induced inflammation for the secondary prevention of cardiovascular diseaseStefan M Nidorf, John W Eikelboom, Peter L Thompson
Current Atherosclerosis Reports|January 16, 2014
Colchicine for secondary prevention of cardiovascular diseaseStefan M Nidorf, John W Eikelboom, Peter L Thompson
Australian and New Zealand Journal of Medicine|October 20, 1998
Refining the risk-benefit equation for thrombolysis: how to identify the low risk patient before administering thrombolytic therapyM Nidorf, R Parsons, P Thompson, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Circulation|January 13, 1999
Assessment of LV mass by echocardiographyM Nidorf, B McQuillan
Journal of the American Heart Association|August 26, 2015
Is There a Role for Colchicine in Acute Coronary Syndromes?Stefan M Nidorf, Subodh Verma
The Medical Journal of Australia|April 17, 1989
Coronary thrombolysisP L Thompson, M Nidorf
The Medical Journal of Australia|October 3, 1988
Coronary thrombolysis: an important therapy for myocardial infarctionM Nidorf, P L Thompson
American Family Physician|December 1, 1995
Proctalgia fugaxD M Nidorf, E R Jamison
The Medical Journal of Australia|January 4, 1988
Valvular surgery in Western Australia: a 15-year reviewM Nidorf, O Tofler, P Gibson, et al.
The Journal of Family Practice|June 1, 1994
Comparison of two topical preparations for the treatment of onychomycosis: Melaleuca alternifolia (tea tree) oil and clotrimazoleD S Buck, D M Nidorf, J G Addino
Journal of Cardiovascular Pharmacology and Therapeutics|September 17, 2013
Targeting cholesterol crystal-induced inflammation for the secondary prevention of cardiovascular diseaseStefan M Nidorf, John W Eikelboom, Peter L Thompson
Current Atherosclerosis Reports|January 16, 2014
Colchicine for secondary prevention of cardiovascular diseaseStefan M Nidorf, John W Eikelboom, Peter L Thompson
Australian and New Zealand Journal of Medicine|October 20, 1998
Refining the risk-benefit equation for thrombolysis: how to identify the low risk patient before administering thrombolytic therapyM Nidorf, R Parsons, P Thompson, et al.
Pageof 5